{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:06:16Z","timestamp":1784142376243,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,15]]},"DOI":"10.7759\/cureus.112738","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:58:03Z","timestamp":1784141883000},"source":"Crossref","is-referenced-by-count":0,"title":["Expanding the Molecular Spectrum of Papillary Renal Neoplasm With Reverse Polarity: A Report of Two Cases and a Literature Review"],"prefix":"10.7759","author":[{"given":"Gang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors","volume":"10","author":"Delahunt B","year":"1997","unstructured":"Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997, 10:537-44.","journal-title":"Mod Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.09.052","article-title":"Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification","volume":"69","author":"Pignot G","year":"2007","unstructured":"Pignot G, Elie C, Conquy S, et al.. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology. 2007, 69:230-5. 10.1016\/j.urology.2006.09.052","journal-title":"Urology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2005.12.002","article-title":"Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases","volume":"10","author":"Hes O","year":"2006","unstructured":"Hes O, Brunelli M, Michal M, et al.. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol. 2006, 10:133-9. 10.1016\/j.anndiagpath.2005.12.002","journal-title":"Ann Diagn Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.05.016","article-title":"Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features","volume":"39","author":"Kunju LP","year":"2008","unstructured":"Kunju LP, Wojno K, Wolf JS Jr, Cheng L, Shah RB. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol. 2008, 39:96-101. 10.1016\/j.humpath.2007.05.016","journal-title":"Hum Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000962","article-title":"Toward biological subtyping of papillary renal cell carcinoma with clinical implications through histologic, immunohistochemical, and molecular analysis","volume":"41","author":"Saleeb RM","year":"2017","unstructured":"Saleeb RM, Brimo F, Farag M, et al.. Toward biological subtyping of papillary renal cell carcinoma with clinical implications through histologic, immunohistochemical, and molecular analysis. Am J Surg Pathol. 2017, 41:1618-29. 10.1097\/PAS.0000000000000962","journal-title":"Am J Surg Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy KI","year":"2019","unstructured":"Al-Obaidy KI, Eble JN, Cheng L, et al.. Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol. 2019, 43:1099-111. 10.1097\/PAS.0000000000001288","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0362-1","article-title":"Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity","volume":"33","author":"Al-Obaidy KI","year":"2020","unstructured":"Al-Obaidy KI, Eble JN, Nassiri M, et al.. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity. Mod Pathol. 2020, 33:1157-64. 10.1038\/s41379-019-0362-1","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01018-6","article-title":"Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity","volume":"35","author":"Al-Obaidy KI","year":"2022","unstructured":"Al-Obaidy KI, Saleeb RM, Trpkov K, et al.. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity. Mod Pathol. 2022, 35:1279-86. 10.1038\/s41379-022-01018-6","journal-title":"Mod Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuroe.2022.05.002","article-title":"Papillary renal cell neoplasm with reverse polarity: a new subtype of renal tumour with favorable prognosis","volume":"46","author":"Conde-Ferreir\u00f3s M","year":"2022","unstructured":"Conde-Ferreir\u00f3s M, Dom\u00ednguez-de Dios J, Juaneda-Magdalena L, et al.. Papillary renal cell neoplasm with reverse polarity: a new subtype of renal tumour with favorable prognosis. Actas Urol Esp (Engl Ed). 2022, 46:600-5. 10.1016\/j.acuroe.2022.05.002","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.930296","article-title":"Papillary renal neoplasm with reverse polarity: a clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity","volume":"12","author":"Shen M","year":"2022","unstructured":"Shen M, Yin X, Bai Y, et al.. Papillary renal neoplasm with reverse polarity: a clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity. Front Oncol. 2022, 12:930296. 10.3389\/fonc.2022.930296","journal-title":"Front Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001455","article-title":"High WHO\/ISUP grade and unfavorable architecture, rather than typing of papillary renal cell carcinoma, may be associated with worse prognosis","volume":"44","author":"Yang C","year":"2020","unstructured":"Yang C, Shuch B, Kluger H, Humphrey PA, Adeniran AJ. High WHO\/ISUP grade and unfavorable architecture, rather than typing of papillary renal cell carcinoma, may be associated with worse prognosis. Am J Surg Pathol. 2020, 44:582-93. 10.1097\/PAS.0000000000001455","journal-title":"Am J Surg Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00990-9","article-title":"Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome","volume":"35","author":"Murugan P","year":"2022","unstructured":"Murugan P, Jia L, Dinatale RG, et al.. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome. Mod Pathol. 2022, 35:825-35. 10.1038\/s41379-021-00990-9","journal-title":"Mod Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32835b682e","article-title":"A novel oncocytoid papillary renal cell carcinoma, type 2, with aberrant cytogenetic abnormalities","volume":"45","author":"Sinniah R","year":"2013","unstructured":"Sinniah R, Teo A, Murch A. A novel oncocytoid papillary renal cell carcinoma, type 2, with aberrant cytogenetic abnormalities. Pathology. 2013, 45:86-8. 10.1097\/PAT.0b013e32835b682e","journal-title":"Pathology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001372","article-title":"A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients","volume":"44","author":"Lau HD","year":"2020","unstructured":"Lau HD, Chan E, Fan AC, et al.. A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients. Am J Surg Pathol. 2020, 44:98-110. 10.1097\/PAS.0000000000001372","journal-title":"Am J Surg Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151734","article-title":"Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: molecular analysis of 39 difficult tumors to classify","volume":"52","author":"Pivovarcikova K","year":"2021","unstructured":"Pivovarcikova K, Grossmann P, Hajkova V, et al.. Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: molecular analysis of 39 difficult tumors to classify. Ann Diagn Pathol. 2021, 52:151734. 10.1016\/j.anndiagpath.2021.151734","journal-title":"Ann Diagn Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.857","article-title":"Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib","volume":"23","author":"Eberhard DA","year":"2005","unstructured":"Eberhard DA, Johnson BE, Amler LC, et al.. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol. 2005, 23:5900-9. 10.1200\/JCO.2005.02.857","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado RG","year":"2008","unstructured":"Amado RG, Wolf M, Peeters M, et al.. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008, 26:1626-34. 10.1200\/JCO.2007.14.7116","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms131012153","article-title":"Prognostic and predictive roles of KRAS mutation in colorectal cancer","volume":"13","author":"Arrington AK","year":"2012","unstructured":"Arrington AK, Heinrich EL, Lee W, et al.. Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci. 2012, 13:12153-68. 10.3390\/ijms131012153","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.06.009","article-title":"Ras proteins and their regulators in human disease","volume":"170","author":"Simanshu DK","year":"2017","unstructured":"Simanshu DK, Nissley DV, McCormick F. Ras proteins and their regulators in human disease. Cell. 2017, 170:17-33. 10.1016\/j.cell.2017.06.009","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/path.4750","article-title":"Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma","volume":"239","author":"Udager AM","year":"2016","unstructured":"Udager AM, McHugh JB, Betz BL, et al.. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma. J Pathol. 2016, 239:394-8. 10.1002\/path.4750","journal-title":"J Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/468153-expanding-the-molecular-spectrum-of-papillary-renal-neoplasm-with-reverse-polarity-a-report-of-two-cases-and-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:58:03Z","timestamp":1784141883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/468153-expanding-the-molecular-spectrum-of-papillary-renal-neoplasm-with-reverse-polarity-a-report-of-two-cases-and-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.112738","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}